ADALIMUMAB-ADAZ

55074 reported adverse events

Drug classes: Tumor Necrosis Factor Blocker [EPC]

These side effects are most commonly reported by patients taking ADALIMUMAB-ADAZ:

# Side effect Count
0 DRUG INEFFECTIVE 11624
1 OFF LABEL USE 9662
2 RHEUMATOID ARTHRITIS 6561
3 PAIN 6472
4 FATIGUE 6470
5 ARTHRALGIA 6308
6 RASH 5346
7 CONDITION AGGRAVATED 5087
8 DIARRHOEA 4907
9 DRUG INTOLERANCE 4718
See all common reactions for ADALIMUMAB-ADAZ

ADALIMUMAB-ADAZ is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 504 0.7545
1 LUPUS VULGARIS 937 0.7437
2 HEPATIC ENZYME 100 0.6711
3 GRIP STRENGTH 142 0.6201
4 DEEP VEIN THROMBOSIS POSTOPERATIVE 1224 0.6111
5 RED BLOOD CELL SEDIMENTATION RATE 167 0.5986
6 FACET JOINT SYNDROME 1861 0.5710
7 SWOLLEN JOINT COUNT INCREASED 1792 0.5614
8 RHEUMATIC FEVER 2499 0.5601
9 CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS 67 0.5583
See all enriched reactions for ADALIMUMAB-ADAZ